Heparin bridging therapy for the patients undergoing total knee arthroplasty

Heparin bridging therapy for the patients undergoing total knee arthroplasty - Heparin bridging therapy for the patients undergoing total knee arthroplasty

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000013661

Enrollment

Registered

2014-04-07

Start date

2014-04-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis, Rheumatoid arthritis, Avascular necrosis of the femoral condyle

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patients who scheduled total knee arthroplasty managed with bridging therapy with heparin

Exclusion criteria

Exclusion criteria: Allergy or intolerance to one of the study drugs.

Design outcomes

Primary

Measure	Time frame
Blood loss	—

Countries

Japan

Contacts

Public ContactSachiyuki Tsukada

Nekoyama Miyao Hospital Orthopaedic Surgery

s8058@nms.ac.jp0252222323

Outcome results